Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Army
Queensland Health
Accenture
Dow
Covington
Colorcon
Chubb
Express Scripts

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,193,998

« Back to Dashboard

Summary for Patent: 6,193,998
Title: Method for producing liposomes with increased percent of compound encapsulated
Abstract:The efficiency of encapsulating a drug into a liposomal formulation is increased by use of a lipid having a carbon chain containing from about 13 to about 28 carbons during preparation of the liposomes. Preferably the liposomes are multivesicular liposomes.
Inventor(s): Ye; Qiang (San Diego, CA), Sankaram; Mantripragada Bhima (San Diego, CA)
Assignee: SkyePharma Inc. (San Diego, CA)
Application Number:09/431,523
Patent Claim Types:
see list of patent claims
Use; Formulation; Compound; Dosage form;

Drugs Protected by US Patent 6,193,998

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 6,193,998

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 4657997 ➤ Try a Free Trial
Australia 738020 ➤ Try a Free Trial
Canada 2267416 ➤ Try a Free Trial
European Patent Office 1005326 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
AstraZeneca
US Army
Express Scripts
Accenture
McKinsey
UBS
Julphar
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.